Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/2012
05/16/2012CN101818150B Neurogenesis
05/15/2012US8178660 Vaccines and immunotherapeutics using codon optimized IL-15 and methods for using the same
05/15/2012US8178508 Methods of stimulating an immune response against prostate specific antigen
05/15/2012US8178507 Method for the modulation of function of transcription factors
05/15/2012US8178506 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
05/15/2012US8178505 Using enzyme specific immunoglobulins and interfering RNA as diagnostic and therapeutic tools in treatment and prevention of cell proliferative disorders
05/15/2012US8178504 Gene therapy expression of GHRH for increasing RBC count in subjects
05/15/2012US8178492 Methods and compositions for modulating adipocyte function
05/15/2012US8178349 Exposing embryonic stem cell to nervous tissue generating nutrient broth and recovering progenitor nervous tissue cells; treating neurological disorders; drug screening
05/15/2012US8178348 For preventing gene transcription/expression; for inducing nuclease stability, hybridization to complementary RNA sequences, permeability to oligonucleotides into cells, RNase cleavage, and blocking ribosome translocation
05/15/2012US8178128 Nanoparticles containing polymeric nucleic acid homologs
05/15/2012US8178111 GM-negative EHV-mutants without heterologous elements
05/15/2012CA2681922C Zinc finger protein derivatives and methods therefor
05/15/2012CA2493859C Preventive/remedy for arteriosclerosis comprising adiponectin
05/15/2012CA2474964C An insulin improving agent containing adiponectin
05/15/2012CA2448933C A retinoic acid metabolizing cytochrome p450
05/15/2012CA2398229C Improved dna vaccines for production-type animals
05/15/2012CA2368385C Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer
05/15/2012CA2367291C Amplification of cyp24 and uses thereof
05/10/2012WO2012061803A2 Compositions and methods for nanopolymer-based nucleic acid delivery
05/10/2012WO2012061537A2 Methods for treating hair loss disorders
05/10/2012WO2012061536A2 Methods for treating hair loss disorders
05/10/2012WO2012061443A2 Compositions of a peptide-based system for cell-specific targeting
05/10/2012WO2012060323A1 Skin and hair color-controlling factor
05/10/2012WO2012060109A1 Method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease
05/10/2012WO2012059612A1 Derivatives of small interfering rnas and use thereof
05/10/2012WO2012059556A1 Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis
05/10/2012WO2012058868A1 Hepatocyte-like cells and uses thereof
05/10/2012WO2012024535A3 Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd)
05/10/2012WO2012024478A3 Treatment of nicotinamide phosphoribosyltransferase (nampt) related diseases by inhibition of natural antisense transcript to nampt
05/10/2012WO2012011952A9 Copy number variant-dependent genes as diagnostic tools, predictive biomarkers and therapeutic targets
05/10/2012WO2011133889A3 NOVEL STRUCTURALLY DESIGNED shRNAs
05/10/2012US20120117674 Method for generating replication defective viral vectors that are helper free
05/10/2012US20120117670 Humanized axl antibodies
05/10/2012US20120116052 Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 Domain
05/10/2012US20120115938 Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
05/10/2012US20120115746 Compositions and methods for treating and diagnosing irritable bowel syndrome
05/10/2012US20120115229 Embryonic stem cells and neural progenitor cells derived therefrom
05/10/2012US20120115136 Pna diagnostic use
05/10/2012US20120114831 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
05/10/2012US20120114759 Peptide/particle delivery systems
05/10/2012US20120114710 Carbon nanotubes complexed with multiple bioactive agents and methods related thereto
05/10/2012US20120114708 Integrin heterodimer and an alpha subunit thereof
05/10/2012US20120114693 Nucleic acid mucosal immunization
05/10/2012US20120114684 Compounds and methods for treatment and diagnosis of chlamydial infection
05/10/2012US20120114660 Antibodies Against LLG Polypeptides of the Triacylglycerol Lipase Family
05/10/2012US20120114619 Protein with promoting effects for axonal growth of neurons of central nervous system
05/10/2012US20120114613 Definitive endoderm cell populations
05/10/2012CA2816913A1 Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis
05/09/2012EP2450053A1 Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis
05/09/2012EP2449113A1 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
05/09/2012EP2213292B1 Double-stranded oligonucleotides
05/09/2012EP1750771B1 Pancreatic islet microrna and methods for inhibiting same
05/09/2012EP1631281B1 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
05/09/2012EP1409506B1 Methods and compositions for rnai mediated inhibition of gene expression in mammals
05/09/2012EP1379337B1 Generation of pharmaceutical agent particles using focused acoustic energy
05/09/2012CN1929866B Enzyme-prodrug therapy for prosthetic joint repair
05/09/2012CN1782072B Vector
05/09/2012CN102449152A Polyion complex of double-stranded ribonucleic acid
05/09/2012CN102448501A Methods and compositions for the treatment of cirrhosis and liver fibrosis
05/09/2012CN102448472A Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
05/09/2012CN102443634A Application of FBP1 (fructose-1,6-bisphosphatase 1) gene
05/09/2012CN102443594A Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application
05/09/2012CN102443582A Gene for promoting insulin secretion, its preparation method and application
05/09/2012CN102443063A Anti-TNFalpha humanized Fab, humanized antibody and its application
05/09/2012CN102441177A Nano bubble carrier for small interfering ribonucleic acid (siRNA) transfer
05/09/2012CN102441176A Application of TGF-beta superfamily gene in preparing medicaments for treating dysmenorrhoea
05/09/2012CN102441175A Hyman serum albumin-siRna nano-sized carrier system
05/09/2012CN102441174A DNA vaccines against hantavirus infections
05/09/2012CN101921763B siRNA capable of inhibiting expression of PAR-1 gene and application thereof
05/09/2012CN101818133B VSIG4 (V-set and Ig domain containing 4) and IGRP (glucose-6-phosphatase catalytic subunit-related protein) dual-gene coexpression recombinant adenovirus as well as preparation method and application thereof
05/09/2012CN101797229B Immune liposome based on Isthmin gene as well as preparation method and application thereof
05/09/2012CN101654686B Multi-target-spot siRNA recombinant slow virus carrier for acquired immune deficiency syndrome gene therapy
05/09/2012CN101623498B Dual-target tumor vaccine based on tumor endothelium marker-8 gene and preparation method thereof
05/09/2012CN101519664B Method for breeding genetically modified animal by using recombinant adenovirus vector
05/09/2012CN101275140B Cysticercosis cellulosae recombination gene, vaccine and preparation thereof
05/09/2012CN101119734B RNAI modulation of RSV and therapeutic uses thereof
05/08/2012US8173796 Oligonucleotide compositions and methods for treating disease including inflammatory conditions
05/08/2012US8173793 Nucleic acids encoding modulators of body weight
05/08/2012US8173786 Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
05/08/2012US8173617 RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
05/08/2012US8173615 TRPM-2 antisense therapy
05/08/2012US8173614 Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof
05/08/2012US8173613 Modulation of mesenchymal and metastatic cell growth
05/08/2012US8173602 Detecting CYP24 expression level as a marker for predisposition to cancer
05/08/2012US8173595 Methods and compositions for the inhibition of thrombus formation
05/08/2012US8173129 Methods and compositions for treating autoimmune diseases
05/08/2012US8173127 Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
05/08/2012US8173125 Wise/Sost nucleic acid sequences and amino acid sequences
05/08/2012US8173121 Lysyl oxidase-like 1 (LOXL1) and elastogenesis
05/08/2012CA2623339C Virulence genes in the vgc2 cluster of salmonella
05/08/2012CA2533338C Viral vectors
05/08/2012CA2520541C Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field
05/08/2012CA2421447C Collections of repeat proteins comprising repeat modules
05/08/2012CA2340593C Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/08/2012CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/03/2012WO2012058693A2 Compositions and methods for inhibition of pcsk9 genes
05/03/2012WO2012058627A2 Pre-targeted nanoparticle system and method for labeling biological particles
05/03/2012WO2012058532A2 Methods and compositions for assessing and treating cancer
05/03/2012WO2012058462A2 Combination therapy for the treatment of cancer
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 870